BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28977161)

  • 1. The relationship between circulating irisin, retinol binding protein-4, adiponectin and inflammatory mediators in patients with metabolic syndrome.
    Tabak O; Simsek G; Erdenen F; Sozer V; Hasoglu T; Gelisgen R; Altunoglu E; Muderrisoglu C; Senyigit A; Uzun H
    Arch Endocrinol Metab; 2017 Dec; 61(6):515-523. PubMed ID: 28977161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating irisin in relation to insulin resistance and the metabolic syndrome.
    Park KH; Zaichenko L; Brinkoetter M; Thakkar B; Sahin-Efe A; Joung KE; Tsoukas MA; Geladari EV; Huh JY; Dincer F; Davis CR; Crowell JA; Mantzoros CS
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4899-907. PubMed ID: 24057291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased irisin versus reduced fibroblast growth factor1 (FGF1) in relation to adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes.
    Saber GY; Kasabri V; Saleh MI; Suyagh M; Halaseh L; Jaber R; Abu-Hassan H; Alalawi S
    Horm Mol Biol Clin Investig; 2019 Mar; 38(1):. PubMed ID: 30840586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of erythrocyte palmitoleic acid with adipokines, inflammatory markers, and the metabolic syndrome in middle-aged and older Chinese.
    Zong G; Ye X; Sun L; Li H; Yu Z; Hu FB; Sun Q; Lin X
    Am J Clin Nutr; 2012 Nov; 96(5):970-6. PubMed ID: 23015321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue dysregulation in patients with metabolic syndrome.
    Bremer AA; Devaraj S; Afify A; Jialal I
    J Clin Endocrinol Metab; 2011 Nov; 96(11):E1782-8. PubMed ID: 21865369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of Plasma Irisin, Adiponectin, and Retinol Binding Protein-4 Levels as Biomarkers for Obstructive Sleep Apnea Syndrome Severity.
    Fazlıoğlu N; Uysal P; Durmus S; Yurt S; Gelisgen R; Uzun H
    Biomolecules; 2023 Sep; 13(10):. PubMed ID: 37892122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs.
    Abu-Farha M; Behbehani K; Elkum N
    Cardiovasc Diabetol; 2014 Apr; 13():76. PubMed ID: 24716628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipokines, inflammatory mediators, and insulin-resistance parameters may not be good markers of metabolic syndrome after liver transplant.
    Anastácio LR; de Oliveira MC; Diniz KG; Ferreira AM; Lima AS; Correia MI; Vilela EG
    Nutrition; 2016 Sep; 32(9):921-7. PubMed ID: 27189907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemerin Ratios to HDL-cholesterol and Adiponectin as Biomarkers of Metabolic Syndrome.
    Shafer-Eggleton J; Adams-Huet B; Jialal I
    Endocr Res; 2020 Nov; 45(4):241-245. PubMed ID: 32835545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of resistin and retinol-binding protein 4 in metabolic syndrome patients with and without prediabetes.
    Horan AA; Albsoul-Younes A; Kasabri V; Suyagh M; Halaseh L; AlAlawi S
    Horm Mol Biol Clin Investig; 2019 Jan; 37(3):. PubMed ID: 30667366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma adiponectin is a more specific marker of fatty liver than a marker of metabolic syndrome in Japanese men.
    Yatsuzuka S; Shimomura Y; Akuzawa M; Ando Y; Kobayashi I; Nakano T; Tokita Y; Nagamine T; Ono H; Tanaka A; Schaefer E; Nakajima K
    Ann Clin Biochem; 2014 Jan; 51(Pt 1):68-79. PubMed ID: 23897104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of circulating irisin with metabolic risk factors in Chinese adults: a cross-sectional community-based study.
    Tang L; Tong Y; Zhang F; Chen G; Zhang YC; Jobin J; Tong N
    BMC Endocr Disord; 2019 Dec; 19(1):147. PubMed ID: 31881940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Relation of Circulating Adipokines to Incident Metabolic Syndrome: The Framingham Heart Study.
    Zachariah JP; Quiroz R; Nelson KP; Teng Z; Keaney JF; Sullivan LM; Vasan RS
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28713076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Zbed3 Levels in Subjects With and Without Metabolic Syndrome.
    Hu W; Tian B; Li X; Li L; Zhang L; Liu H; Yang G; Liu Y; Fan X
    Metab Syndr Relat Disord; 2017 Jun; 15(5):207-212. PubMed ID: 28346859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDL2-cholesterol/HDL3-cholesterol ratio was associated with insulin resistance, high-molecular-weight adiponectin, and components for metabolic syndrome in Japanese.
    Moriyama K; Negami M; Takahashi E
    Diabetes Res Clin Pract; 2014 Nov; 106(2):360-5. PubMed ID: 25201260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum irisin with metabolic syndrome in obese Chinese adults.
    Yan B; Shi X; Zhang H; Pan L; Ma Z; Liu S; Liu Y; Li X; Yang S; Li Z
    PLoS One; 2014; 9(4):e94235. PubMed ID: 24709991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers.
    Devaraj S; Swarbrick MM; Singh U; Adams-Huet B; Havel PJ; Jialal I
    Am J Clin Pathol; 2008 May; 129(5):815-22. PubMed ID: 18426744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipokines and endothelial dysfunction in obesity WHO°III.
    Bachmayer C; Kemmer A; Ehrmann N; Hasenberg T; Lammert A; Hammes HP
    Microvasc Res; 2013 Sep; 89():129-33. PubMed ID: 23648313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Irisin, Adiponectin and Leptin Levels in Patients with Schizophrenia.
    Erzin G; Topcuoglu C; Kotan VO; Bayram S; Fountoulakis K
    Endocr Metab Immune Disord Drug Targets; 2018 Feb; 18(2):163-169. PubMed ID: 29219062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.